Browse the detailed record of transactions filed by Dolsten Mikael, Director. Officer active across 3 companies, notably Agilent Technologies, INC.. In total, 13 disclosures have been recorded. Total volume traded: €9k. The latest transaction was filed on 11 May 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Mikael Dolsten is a Director and President of R&D at Agilent Technologies, Inc., Pfizer Inc, and Apellis Pharmaceuticals, Inc. He plays a key role on the boards, bringing his expertise in research and development. His experience allows him to contribute to innovation and strategy for these companies.